期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

器官移植后新发糖尿病的降糖药物的合理使用 被引量：1

原文传递
导出
摘要 糖尿病是实体器官移植后常见的代谢性并发症，如受者术后2年的2型糖尿病发病率约为30％。据报道，肾移植后新发糖尿病（NODAT）导致移植肾功能丧失的发生率（63％）上升，受者的死亡率达87％，不仅影响移植物功能的恢复，还使心血管疾病的发病率和受者的死亡率升高。因此，NODAT的监测和管理是移植后的重要环节，器官移植后新发糖尿病时降糖药物的合理使用应引起关注，现就此做如下综述。
作者 常瑛 文爱东 曹青 李红 田云
机构地区 第四军医大学西京医院药剂科 西安市第二医院药剂科 西电集团医院药剂科
出处 《中华器官移植杂志》 CAS CSCD 北大核心 2013年第2期126-128,共3页 Chinese Journal of Organ Transplantation
关键词 2型糖尿病 降糖药物 移植后 器官 肾功能丧失 心血管疾病 发病率 死亡率
分类号 R587.1 [医药卫生—内分泌]
  • 相关文献

参考文献16

  • 1Chen T,Jia H,Li J. New onset diabetes mellitus after liver transplantation and hepatitis C virus infection:meta-analysis of clinical studies[J].Transplant International,2009,(04):408-415.doi:10.1111/j.1432-2277.2008.00804.x.
  • 2Grundy SM. Metabolic syndrome:a multiplex cardiovascular risk factor[J].Journal of Clinical Endocrinology and Metabolism,2007,(02):399-404.
  • 3Peacock TP,Shihabi ZK,Bleyer AJ. Comparison of glycated albumin and hemoglobin A (1c) levels in diabetic subjects on hemodialysis[J].Kidney International,2008,(09):1062-1068.
  • 4Kuo HT,Sampaio MS,Ye X. Risk factors for newonset diabetes mellitus in adult liver transplant recipients,an analysis of the Organ Procurement and Transplant Network/United Network for Organ Sharing database[J].Transplantation,2010,(09):1134-1140.
  • 5Vincenti F,Friman S,Scheuermann E. Results of an international,randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus[J].American Journal of Transplantation,2007,(06):1506-1514.doi:10.1111/j.1600-6143.2007.01749.x.
  • 6Woodle ES,First MR,Pirsch J. A prospective,randomized,double-blind,placebo-controlled multicenter trial comparing early (7 day) corticosteroid cessation versus longterm,low-dose corticosteroid therapy[J].Annals of Surgery,2008,(04):564-577.
  • 7Nathan DM,Buse JB,Davidson MB. Medical management of hyperglycemia in type 2 diabetes:a consensus algorithm for the initiation and adjustment of therapy:a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes[J].Diabetes Care,2009,(01):193-203.doi:10.2337/dc08-9025.
  • 8Kahn SE,Haffner SM,Heise MA. Glycemic durability of rosiglitazone,metformin,or glyburide monotherapy[J].New England Journal of Medicine,2006.2427-2443.
  • 9Voytovich MH,Haukereid C,Hjelmesaeth J. Nateglinide improves postprandial hyperglycemia and insulin secretion in renal transplant recipients[J].Clinical Transplantation,2007,(02):246-2451.
  • 10Baldwin D Jr,Duffin KE. Rosiglitazone treatment of diabetes mellitus after solid organ transplantation[J].Transplantation,2004,(07):1009-1014.

同被引文献65

  • 1赵胜利,刘红,吴红霞,翁世艾,秦保明.山莨菪碱对环孢素A所致大鼠胰腺毒性的防护作用[J].河南医科大学学报,1994,29(4):324-327. 被引量：3
  • 2Prokai A, Fekete A, Pasti K, Rusai K, Banki NF, Reusz G, Szabo AJ. The importance of different im- munosuppressive regimens in the development of posttransplant diabetes mellitus. Pediatr Diabetes 2012. 13:81-91 [PMID: 21595806 DOI: 10.1111/ j.1399-5448.2011.00782.x].
  • 3Haddi EM, McAlister VC, Renouf E, Malthaner R, Kjaer MS, Gluud LL. Cyclosporin versus tacrolimus for liver transplanted patients. Cochrane Database Syst Rev 2006. (4): CD005161 [PMID: 17054241 DOI: 10.1002/14651858.CD005161.pub2].
  • 4Almeida CC, Silveira MR, de Aratijo VE, de Lemos LL, de Oliveira Costa J, Reis CA, de Assis Acurcio F,das Gracas Braga Ceccato M. Safety of immunosupt pressive drugs used as maintenance therapy in kidt ney transplantation: a systematic review and meta analysis. Pharmaceuticals (Basel) 2013. 6: 1170-119 [PMID: 24275847 DOI: 10.3390/ph6101170].
  • 5Jansson D, Ng AC, Fu A, Depatie C, A1 Azzabi M, Screaton RA. Glucose controls CREB activity in islet cells via regulated 15hosphorylation of TORC2. Proc Natl Acad Sci U S A 2008. 105:10161-10166 [PMID: 18626018 DOI: 10.1073/pnas.0800796105].
  • 6Niu YJ, Shen ZY, XuC, Li CF, Liu XJ. Teng YQ, Chen H, Li L, Cheng HM, Yang XM, Mao S. Es- tablishment of tacrolimus-induced diabetes in rat model and assessment of clinical treatments for post-transplant diabetes mellitus in liver trans- plant recipients. Clin Lab 2013. 59:869-874 [PMID: 24133918].
  • 7Eberhard-CE, Fu A, Reeks C, Screaton RA. CRTC2 is required for D-cell function and proliferation. Endocrinology 2013. 154:2308-2317 [PMID: 23677932 DOI: 10.1210/en.2012-2088].
  • 8i j Chakkera HA, Mandarino LJ. Calcineurin inhibi- tion and new-onset diabetes mellitus after trans- plantation. Transplantation 2013. 95:647-652 [PMID: 23076551 DOI: 10.1097/TP.0b013e31826e592e].
  • 9Froud T, Faradji RN, Pileggi A, Messinger S, Baidal DA, Ponte GM, Cure PE, Monroy K, Mendez A, Selvaggi G, Ricordi C, Alejandro R. The use of ex- enatide in islet transplant recipients with chronic allograft dysfunction: safety, efficacy, and meta- bolic effects. Transplantation 2008. 86:36-45 [PMID: 18622276 DOI: 10.1097/TP.0b013e31817c4ab3|.
  • 10Haidinger M, Werzowa J, Hecking M, Antlanger M, Sterner G, Pleiner J, Kopecky C, Kovarik JJ, D011er D, Pacini G, Siemann MD. Efficacy and safety of vildagliptin in new-onset diabetes after kidney transplantation--a randomized, double-blind, place- bo-controlled trial. Am J Transplant 2014. 14:115-123 [PMID: 24279801 DOI: 10.1111/ajt.12518].

引证文献1

二级引证文献3

中华器官移植杂志
2013年 第2期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部